Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 0.3% GSK1940029 gel
Total 0 results
Nothing found
Sponsors and Collaborators
Hospital Durand, Argentina
Mª Victoria Maestre Sanchez
RMIT University, Melbourne, Australia
Eurofins Genoma
Alma Lasers Inc.
Korean Society of Spine Surgery
Apollo Neuroscience, Inc.
Kupfer, David J., M.D.
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Aptis Medical
Nacuity Pharmaceuticals, Inc.
Hospital ASEPEYO Sant Cugat
Neurophth Therapeutics Inc
ASST Cremona, Cremona
iCAD
Everett Meyer
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
GFI
Agency for Science, Technology and Research
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
View Full List
Medical Conditions
T-LGL Leukemia
Gastric Cancer Stage IIIB-IIIC
Recurrent Clear Cell Sarcoma of Soft Tissue
RISS Stage III Plasma Cell Myeloma
Scleredema
Corneal Cross-Linking
Major Liver Surgery
Chronic Constipation Symptoms
Splenic Trauma
Disorder of Fluid Balance
The Strength Properties of the Aorta in Vitro
Fever
Immune-Mediated Inflammatory Disease
Luteal Phase Support
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Rheumatoid Arthritis(RA)
Treatment Decisions
Metachronous Adenoma
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Dienogest
View Full List
Drug Interventions
RDX227675
MLN2480
Standard of care (SOC) for COVID-19
Intravenous deferiprone
Anticholinergic
Olopatadine
Letrozole
OnabotulinumtoxinA
Midazolam
Intravenous Formulation of PD-0332991
TPN-101
Fospropofol disodium, propofol
Oxycodone/acetaminophen 5/325 mg
Camptosar
GLPG1837 multiple ascending doses
Capecitabine/cisplatin
Desvenlafaxine
Capecitabine and IMRT (if randomized to this arm)
THC
PD-1/PD-L1 inhibitor
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Colombia
Contract Research Organizations in Costa Rica
Contract Research Organizations in Georgia
Contract Research Organizations in Ghana
Contract Research Organizations in Jamaica
Contract Research Organizations in Kosovo
Contract Research Organizations in Pakistan
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Tanzania
Contract Research Organizations in Thailand
Contract Research Organizations in Uzbekistan
CRO list by country
CROs in Malawi
SGS
All CROs in Malawi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe